• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CELLESTIS INC CELLESTIS; QUANTIFERON TB GOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CELLESTIS INC CELLESTIS; QUANTIFERON TB GOLD Back to Search Results
Catalog Number T0590-0301
Device Problems Nonstandard Device (1420); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/09/2012
Event Type  malfunction  
Manufacturer Narrative
As a result of a capa investigation, historical complaints were found that were identified as requiring a medwatch report.The company has decided to submit this mdr for information purposes to ensure full compliance with 21cfr part 803.(b)(4).
 
Event Description
Cellestic customer (b)(4) received where customer reported that they drew 5 samples on monday ((b)(6)) before training.During the first day of training , the samples were run and all resulted as positive.They stated that they had worked in many different labs in the hospitals and with lots of patients.That same day the samples were redrawn plus an additional 2 samples.They repeated as positive on the second day of training, with the additional 2 samples as negative.The validation samples that were supplied resulted as expected with a mixture of positives and negative results.The customer sent the 7 tubes that were drawn for the second day of testing to their lab in sioux falls, and they confirmed the positive and negative results.The customer then ordered a new tube lot and redrew the same 7 samples.They ran these samples in their lab and sent them to mayo to run.All are negative.They are convinced that it is the lot of tubes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLESTIS
Type of Device
QUANTIFERON TB GOLD
Manufacturer (Section D)
CELLESTIS INC
28358 constellation road
unit 698
valencia 91355
Manufacturer (Section G)
CELLESTIS INC
28358 constellation road
valencia MD 01355
Manufacturer Contact
donna sowers
19300 germantown road
germantown, MD 20874
2406867876
MDR Report Key5408484
MDR Text Key38236281
Report Number1122376-2016-00002
Device Sequence Number1
Product Code NCD
UDI-Device Identifier04053228002109
UDI-Public04053228002109
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Reporter Occupation Other
Remedial Action Recall
Type of Report Initial
Report Date 02/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/03/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date02/28/2013
Device Catalogue NumberT0590-0301
Device Lot NumberA111103N
Was Device Available for Evaluation? No
Date Manufacturer Received07/09/2012
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number3003964343-01/28/13-001R
Patient Sequence Number1
-
-